AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28900859 — intervention group
Group type: EXPERIMENTAL
Intervention: Surah Al‐Rehman recited by Qari Abdul Basit, 12 structured group sessions of 22 min, two times a day for 4 weeks
Number of subjects: 12
Study 28900859 — intervention group
Group type: COMPARATOR
Intervention: Music used for relaxation and treatment of depression, 12 structured group sessions of 22 min, two times a day for 4 weeks
Number of subjects: 12
Study 29203355 — intervention group
Group type: EXPERIMENTAL
Intervention: drisapersen 6 mg/kg/week
Number of subjects: 186
Study 29203355 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 186
Study 26433369 — intervention group
Group type: EXPERIMENTAL
Intervention: Plan My Life (PML)
Number of subjects: 159
Study 26433369 — intervention group
Group type: COMPARATOR
Intervention: Solution-Focused Therapy (SFT)
Number of subjects: 159
Study 24643315 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence support interventions (individual counselling and structured theory-based adherence support program)
Number of subjects: 889
Study 22884052 — intervention group
Group type: EXPERIMENTAL
Intervention: Mask preconditioning (MaG)
Number of subjects: 160
Study 22884052 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam pretreatment (MiG)
Number of subjects: 160
Study 22884052 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of mask preconditioning and midazolam (Ma/MiG)
Number of subjects: 160
Study 22884052 — intervention group
Group type: COMPARATOR
Intervention: Saline group (SaG)
Number of subjects: 160
Study 21337773 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program about Ca, PO4 and PTH metabolism
Number of subjects: 33
Study 21337773 — intervention group
Group type: COMPARATOR
Intervention: Information on vascular access (Control)
Number of subjects: 33
Study 21337773 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program
Number of subjects: 33
Study 21337773 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 33
Study 17279847 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstract meaning manipulation of compliments
Number of subjects: 3
Study 17204525 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild stimulation regimen using GnRH antagonist co‐treatment (67 patients)
Number of subjects: 111
Study 17204525 — intervention group
Group type: COMPARATOR
Intervention: Conventional high‐dose exogenous gonadotrophin regimen and GnRH agonist co‐treatment (44 patients)
Number of subjects: 111
Study 15700748 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 ml olive oil with high phenolic content
Number of subjects: 12
Study 15700748 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 ml olive oil with moderate phenolic content
Number of subjects: 12
Study 15700748 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 ml olive oil with low phenolic content
Number of subjects: 12
Study 15700748 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 ml olive oil with moderate and high phenolic content
Number of subjects: 12
Study 10855596 — intervention group
Group type: EXPERIMENTAL
Intervention: Delirium present
Number of subjects: 126
Study 10855596 — intervention group
Group type: EXPERIMENTAL
Intervention: Delirium persisted at 1 month
Number of subjects: 126
Study 9186538 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF and 200 IU/kg of EPO (group L)
Number of subjects: 131
Study 9186538 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF and 400 IU/kg of EPO (group H)
Number of subjects: 131
Study 9186538 — intervention group
Group type: COMPARATOR
Intervention: G-CSF alone (group C)
Number of subjects: 131
Study 1590582 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 0.5%
Number of subjects: 146
Study 1590582 — intervention group
Group type: COMPARATOR
Intervention: lidocaine 2%
Number of subjects: 146
Study 2418302 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (20-30 mg three times daily)
Number of subjects: 15
Study 2418302 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (with pindolol as second-step treatment)
Number of subjects: 15
Study 2418302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 2418302 — intervention group
Group type: COMPARATOR
Intervention: Placebo (with pindolol as second-step treatment)
Number of subjects: 15
Study 30746532 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive oral health care
Number of subjects: 187
Study 30746532 — intervention group
Group type: COMPARATOR
Intervention: Oral health examination (Control)
Number of subjects: 187
Study 28012485 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (10 mg/day)
Number of subjects: 478
Study 28012485 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 478
Study 25299536 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration training
Number of subjects: 30
Study 25299536 — intervention group
Group type: COMPARATOR
Intervention: Control group (designed physical therapy program)
Number of subjects: 30
Study 23202590 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone tape
Number of subjects: 28
Study 23202590 — intervention group
Group type: EXPERIMENTAL
Intervention: Paper tape
Number of subjects: 28
Study 23202590 — intervention group
Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 28
Study 21570659 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP
Number of subjects: 53
Study 21570659 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 53
Study 18812844 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine hydrochloride, 0.2 mg/kg, by submucous infiltration of the proposed incisional site
Number of subjects: 20
Study 18812844 — intervention group
Group type: COMPARATOR
Intervention: Control group (no medication before surgery)
Number of subjects: 20
Study 17181880 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training (n=12)
Number of subjects: 18
Study 17181880 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=6)
Number of subjects: 18
Study 12709722 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole, 200 mg once daily for 5 days with 10 mg rosuvastatin coadministered on day 4 (trial A)
Number of subjects: 26
Study 12709722 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole, 200 mg once daily for 5 days with 80 mg rosuvastatin coadministered on day 4 (trial B)
Number of subjects: 26
Study 12709722 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 11766002 — intervention group
Group type: EXPERIMENTAL
Intervention: Rubella IgG antibody testing using ELISA technique
Number of subjects: 609
Study 11766002 — intervention group
Group type: EXPERIMENTAL
Intervention: Age group 15-20 years
Number of subjects: 609
Study 11766002 — intervention group
Group type: EXPERIMENTAL
Intervention: Age group 31-36 years
Number of subjects: 609
Study 11766002 — intervention group
Group type: EXPERIMENTAL
Intervention: Age group >36 years
Number of subjects: 609
Study 11766002 — intervention group
Group type: COMPARATOR
Intervention: Housewives vs service-holders
Number of subjects: 609
Study 8605125 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotomy followed by oxytocin infusion after 1 h (group A, n = 98)
Number of subjects: 196
Study 8605125 — intervention group
Group type: COMPARATOR
Intervention: Amniotomy alone (group B, n = 98)
Number of subjects: 196
Study 8605125 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotomy followed by oxytocin infusion (group A)
Number of subjects: 196
Study 8605125 — intervention group
Group type: COMPARATOR
Intervention: Amniotomy alone (group B)
Number of subjects: 196
Study 8605125 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 196
Study 1622981 — intervention group
Group type: EXPERIMENTAL
Intervention: Chicken sandwich made with white bread
Number of subjects: 11
Study 1622981 — intervention group
Group type: COMPARATOR
Intervention: Chicken sandwich made with wholemeal bread
Number of subjects: 11
Study 3903783 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified 'Rotahaler'
Number of subjects: 396
Study 3903783 — intervention group
Group type: COMPARATOR
Intervention: Standard model 'Rotahaler'
Number of subjects: 396
Study 30587926 — intervention group
Group type: EXPERIMENTAL
Intervention: Vardenafil hydrochloride (20 mg tablets)
Number of subjects: 24
Study 30587926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 30567826 — intervention group
Group type: EXPERIMENTAL
Intervention: Plaster cast immobilisation
Number of subjects: 478
Study 30567826 — intervention group
Group type: COMPARATOR
Intervention: Functional brace
Number of subjects: 478
Study 30567826 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life and resource use
Number of subjects: 478
Study 27783767 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sedation with midazolam
Number of subjects: 50
Study 27783767 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sedation with midazolam/ketamine
Number of subjects: 50
Study 27783767 — intervention group
Group type: COMPARATOR
Intervention: No sedative
Number of subjects: 50
Study 27783767 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 50
Study 24684966 — intervention group
Group type: EXPERIMENTAL
Intervention: Toric intraocular lens (IOL) implantation
Number of subjects: 34
Study 24684966 — intervention group
Group type: COMPARATOR
Intervention: Astigmatic keratotomy (AK)
Number of subjects: 34
Study 22893340 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse practitioner and pharmacist consultations
Number of subjects: 120
Study 20377476 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg and simvastatin 20 mg/day
Number of subjects: 0
Study 20377476 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20377476 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe or combination of ezetimibe and simvastatin
Number of subjects: 0
Study 17616486 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored Internet
Number of subjects: 249
Study 17616486 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored Print
Number of subjects: 249
Study 17616486 — intervention group
Group type: COMPARATOR
Intervention: Standard Internet
Number of subjects: 249
Study 15086174 — intervention group
Group type: EXPERIMENTAL
Intervention: En-bloc spleno-pancreatic and vascular resection with adjuvant locoregional chemoimmunotherapy
Number of subjects: 56
Study 15086174 — intervention group
Group type: COMPARATOR
Intervention: Palliative gastro-biliary bypass with adjuvant locoregional chemoimmunotherapy
Number of subjects: 56
Study 11324984 — intervention group
Group type: EXPERIMENTAL
Intervention: INS365 ophthalmic solution (0.5%, 1.0%, 2.0%, 5.0%)
Number of subjects: 50
Study 11324984 — intervention group
Group type: EXPERIMENTAL
Intervention: INS365 ophthalmic solution (5.0%)
Number of subjects: 50
Study 11324984 — intervention group
Group type: COMPARATOR
Intervention: INS365 ophthalmic solution
Number of subjects: 50
Study 10374509 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral feeding (EFg)
Number of subjects: 0
Study 10374509 — intervention group
Group type: COMPARATOR
Intervention: Delayed feeding (DFg)
Number of subjects: 0
Study 8433151 — intervention group
Group type: EXPERIMENTAL
Intervention: AGM-1470 treatment
Number of subjects: 348
Study 8433151 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 348
Study 3630929 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (IS-5MN) 20 mg
Number of subjects: 21
Study 3630929 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (IS-5MN) 40 mg
Number of subjects: 21
Study 3630929 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 30260376 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% paromomycin in Aquaphilic
Number of subjects: 80
Study 30260376 — intervention group
Group type: COMPARATOR
Intervention: Aquaphilic vehicle
Number of subjects: 80
Study 30260376 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional pentamidine
Number of subjects: 80
Study 30328688 — intervention group
Group type: EXPERIMENTAL
Intervention: Pycnogenol supplementation
Number of subjects: 30
Study 30328688 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control)
Number of subjects: 30
Study 25923226 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic Continuous Positive Airway Pressure (ACPAP)
Number of subjects: 161
Study 25923226 — intervention group
Group type: COMPARATOR
Intervention: Optimum Continuous Positive Airway Pressure (CPAP)
Number of subjects: 161
Study 24472342 — intervention group
Group type: EXPERIMENTAL
Intervention: CIEMR (Circumferential Incision EMR)
Number of subjects: 59
Study 24472342 — intervention group
Group type: COMPARATOR
Intervention: EMR (Conventional EMR)
Number of subjects: 59
Study 22082706 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered cognitive behavioral therapy (TCBT)
Number of subjects: 442
Study 22082706 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded exercise
Number of subjects: 442
Study 22082706 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention
Number of subjects: 442
Study 22082706 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 442
Study 21133303 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment and management of cardiovascular risk factors by general practitioners and practice nurses
Number of subjects: 63
Study 21133303 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice for high risk patients to exercise more
Number of subjects: 63
Study 21133303 — intervention group
Group type: EXPERIMENTAL
Intervention: Management of obesity/overweight, pre-diabetes, and high lipids
Number of subjects: 63
Study 21133303 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of dietary advice and referral
Number of subjects: 63
Study 17613798 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher working memory capacity (WMC)
Number of subjects: 0
Study 17613798 — intervention group
Group type: COMPARATOR
Intervention: Lower working memory capacity (WMC)
Number of subjects: 0
Study 15774253 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 50mg
Number of subjects: 30
Study 15774253 — intervention group
Group type: EXPERIMENTAL
Intervention: Apomorphine SL 2mg
Number of subjects: 30
Study 15774253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 12368971 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily movement (passive range of motion with gentle compression of both the upper and lower extremities, 5 days per week for 4 weeks)
Number of subjects: 20
Study 12368971 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily movement
Number of subjects: 20
Study 12368971 — intervention group
Group type: COMPARATOR
Intervention: Control (no daily movement)
Number of subjects: 20
Study 10606278 — intervention group
Group type: EXPERIMENTAL
Intervention: Diverse treatments including radiation therapy, surgery, chemotherapy, and supportive measures
Number of subjects: 0
Study 8712751 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg Keyhole limpet hemocyanin (KLH) intracutaneously followed by 20 mg KLH intravesically in 20 ml saline for 6 weeks, then monthly for one year and bimonthly for 2 subsequent years
Number of subjects: 9
Study 1930698 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer dentifrice (0.3% triclosan, 2.0% Gantrez copolymer, 0.243% sodium fluoride/silica)
Number of subjects: 108
Study 1930698 — intervention group
Group type: COMPARATOR
Intervention: Placebo dentifrice (0.243% sodium fluoride/silica)
Number of subjects: 108
Study 6759814 — intervention group
Group type: EXPERIMENTAL
Intervention: Anapsos 120 mg
Number of subjects: 37
Study 6759814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 31599965 — intervention group
Group type: EXPERIMENTAL
Intervention: Hard water (> 257 mg L−1 CaCO3)
Number of subjects: 1303
Study 31599965 — intervention group
Group type: COMPARATOR
Intervention: Soft water (≤ 257 mg L−1 CaCO3)
Number of subjects: 1303
Study 31599965 — intervention group
Group type: EXPERIMENTAL
Intervention: Hard water plus FLG mutations
Number of subjects: 1303
Study 31599965 — intervention group
Group type: EXPERIMENTAL
Intervention: Hard water
Number of subjects: 1303
Study 30136029 — intervention group
Group type: EXPERIMENTAL
Intervention: Carnosine 1g twice daily for 12 weeks
Number of subjects: 26
Study 30136029 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 28193198 — intervention group
Group type: EXPERIMENTAL
Intervention: Microfinance combined with gender training
Number of subjects: 1049
Study 25929612 — intervention group
Group type: EXPERIMENTAL
Intervention: Micafungin (1 mg/kg for candidiasis, 1 to 3 mg/kg for aspergillosis, up to 6 mg/kg once daily if required)
Number of subjects: 201
Study 24526760 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard duration intervention program (17 sessions, 1.5 months)
Number of subjects: 20
Study 24526760 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention program (11 sessions, 1 month)
Number of subjects: 20
Study 24526760 — intervention group
Group type: COMPARATOR
Intervention: Wait-list group (control)
Number of subjects: 20
Study 22470539 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 30280
Study 22470539 — intervention group
Group type: COMPARATOR
Intervention: Chlorthalidone
Number of subjects: 30280
Study 22470539 — intervention group
Group type: COMPARATOR
Intervention: Lisinopril
Number of subjects: 30280
Study 22470539 — intervention group
Group type: EXPERIMENTAL
Intervention: NOS3 -690 C>T (rs3918226)
Number of subjects: 30280
Study 22470539 — intervention group
Group type: EXPERIMENTAL
Intervention: NOS3 -922 A>G (rs1800779)
Number of subjects: 30280
Study 19364294 — intervention group
Group type: EXPERIMENTAL
Intervention: EFA supplementation (480 mg of linoleic acid and 120 mg of alpha-linolenic acid)
Number of subjects: 73
Study 19364294 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1000 mg of vitamin C)
Number of subjects: 73
Study 17263800 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral liarozole 75 mg in the morning and 75 mg in the evening for 12 weeks
Number of subjects: 32
Study 17263800 — intervention group
Group type: COMPARATOR
Intervention: Acitretin 10 mg in the morning and 25 mg in the evening for 12 weeks
Number of subjects: 32
Study 15529729 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 54
Study 15529729 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine
Number of subjects: 54
Study 10839585 — intervention group
Group type: EXPERIMENTAL
Intervention: Abacavir (ABC) + Stable Background Therapy (SBG)
Number of subjects: 185
Study 10839585 — intervention group
Group type: COMPARATOR
Intervention: Stable Background Therapy (SBG) alone
Number of subjects: 185
Study 10839585 — intervention group
Group type: EXPERIMENTAL
Intervention: Abacavir (ABC) + SBG
Number of subjects: 185
Study 9175045 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of 200 units of 1,34‐PTH
Number of subjects: 10
Study 9175045 — intervention group
Group type: COMPARATOR
Intervention: Sham infusion
Number of subjects: 10
Study 8267303 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained classroom teachers
Number of subjects: 550
Study 8267303 — intervention group
Group type: EXPERIMENTAL
Intervention: PE specialists
Number of subjects: 550
Study 8267303 — intervention group
Group type: COMPARATOR
Intervention: Control (usual PE)
Number of subjects: 550
Study 8267303 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions (trained teachers and PE specialists)
Number of subjects: 550
Study 8267303 — intervention group
Group type: EXPERIMENTAL
Intervention: PE intervention
Number of subjects: 550
Study 3921124 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation group (taught breathing exercises, relaxation, meditation, and stress management)
Number of subjects: 192
Study 3921124 — intervention group
Group type: COMPARATOR
Intervention: Control group (received health education leaflets only)
Number of subjects: 192
Study 3921124 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 192
Study 3921124 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation group
Number of subjects: 192
Study 2853194 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuIFN‐gamma (2 Mu i.n. 3 x /day)
Number of subjects: 27
Study 2853194 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 31752544 — intervention group
Group type: EXPERIMENTAL
Intervention: Active (blue‐light filtering glasses)
Number of subjects: 30
Study 31752544 — intervention group
Group type: COMPARATOR
Intervention: Placebo (glasses without filtering properties)
Number of subjects: 30
Study 30338774 — intervention group
Group type: EXPERIMENTAL
Intervention: EPDS (Edinburgh Postnatal Depression Scale)
Number of subjects: 1204
Study 30338774 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-factor model (anxiety, depression, anhedonia) confirmed by CFA
Number of subjects: 1204
Study 28394665 — intervention group
Group type: COMPARATOR
Intervention: Q-switched Nd:YAG laser (1064 nm) alone
Number of subjects: 60
Study 28394665 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ablative ultrapulse CO2 followed by fixed-dose QS Nd:YAG laser (1064 nm)
Number of subjects: 60
Study 26289682 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Music Therapy (MT)
Number of subjects: 120
Study 26289682 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized Listening to Music (LtM)
Number of subjects: 120
Study 26289682 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 120
Study 26289682 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (MT, LtM, SC)
Number of subjects: 120
Study 24090805 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1)
Number of subjects: 46
Study 24090805 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 21936956 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly low dose zoledronic acid
Number of subjects: 60
Study 21936956 — intervention group
Group type: COMPARATOR
Intervention: Conventional dosage of zoledronic acid
Number of subjects: 60
Study 18179855 — intervention group
Group type: EXPERIMENTAL
Intervention: Carisolv treatment for 30 seconds followed by excavation with a dental explorer
Number of subjects: 50
Study 18179855 — intervention group
Group type: COMPARATOR
Intervention: Bristle brush with prophylaxis paste
Number of subjects: 50